569
Views
24
CrossRef citations to date
0
Altmetric
Review

Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression

, , , , &
Pages 153-166 | Received 06 Sep 2016, Accepted 24 Oct 2016, Published online: 16 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Cynthia V. Calkin. (2019) Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder. Annals of Medicine 51:5-6, pages 281-293.
Read now
Eva Ceskova & Petr Silhan. (2018) Novel treatment options in depression and psychosis. Neuropsychiatric Disease and Treatment 14, pages 741-747.
Read now

Articles from other publishers (22)

Agata Zięba, Dariusz Matosiuk & Agnieszka A. Kaczor. (2023) The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery. International Journal of Molecular Sciences 24:3, pages 2946.
Crossref
Anna Carotenuto, Angiola Maria Fasanaro, Valentino Manzo, Francesco Amenta & Enea Traini. (2022) Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer’s Disease. Journal of Alzheimer's Disease Reports 6:1, pages 235-243.
Crossref
Sheng Wang, Guilan Huang, Jie Yan, Changxi Li, Jianwen Feng, Qi Chen, Xiaomeng Zheng, Haobin Li, Jiangchao Li, Lijing Wang & Huimin Li. (2021) Influence of aging on chronic unpredictable mild stress-induced depression-like behavior in male C57BL/6J mice. Behavioural Brain Research 414, pages 113486.
Crossref
Rachel E. Teneralli, David M. Kern, M. Soledad Cepeda, James P. Gilbert & Wayne C. Drevets. (2021) Exploring real-world evidence to uncover unknown drug benefits and support the discovery of new treatment targets for depressive and bipolar disorders. Journal of Affective Disorders 290, pages 324-333.
Crossref
Ulderico Freo, Viola Brugnatelli, Fabio Turco & Gastone Zanette. (2021) Analgesic and Antidepressant Effects of the Clinical Glutamate Modulators Acetyl-L-Carnitine and Ketamine. Frontiers in Neuroscience 15.
Crossref
Concetta Crisafulli, Marco Calabrò, Laura Mandelli, Sheng-Min Wang, Soo-Jung Lee, Changsu Han, Ashwin Patkar, Prakash Masand, Chi-Un Pae, Daniel Souery, Julien Mendlewicz & Alessandro Serretti. (2021) Possible Modulatory Role of ARC Gene Variants in Mood Disorders. Clinical Psychopharmacology and Neuroscience 19:1, pages 46-52.
Crossref
Elnaz Roohi, Nematollah Jaafari & Farshad Hashemian. (2021) On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?. Journal of Neuroinflammation 18:1.
Crossref
Guang Chen, Rodrigo Machado-Vieira, Carlos A. Zarate & Husseini K. Manji. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1004 1010 .
Guang Chen, Rodrigo Machado-Vieira, Carlos A. Zarate & Husseini K. Manji. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1 7 .
I. A. Novakov, D. S. Sheikin, M. B. Navrotskii, A. S. Mkrtchyan, L. L. Brunilina & K. V. Balakin. (2020) Dexoxadrol and its bioisosteres: structure, synthesis, and pharmacological activity. Russian Chemical Bulletin 69:9, pages 1625-1671.
Crossref
Maryam Ardalan, Betina Elfving, Ali H. Rafati, Monireh Mansouri, Carlos A. ZarateJrJr, Aleksander A. Mathe & Gregers Wegener. (2020) Rapid effects of S-ketamine on the morphology of hippocampal astrocytes and BDNF serum levels in a sex-dependent manner. European Neuropsychopharmacology 32, pages 94-103.
Crossref
Michele Tufano & Graziano Pinna. (2020) Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?. Molecules 25:5, pages 1062.
Crossref
M.C. Flux & Christopher A. Lowry. (2020) Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience. Neurobiology of Disease 135, pages 104578.
Crossref
Suélen Osório Heck, Vanessa Angonesi Zborowski, Simone Pinton & Cristina Wayne Nogueira. (2019) Pro-apoptotic cell signaling in the prefrontal cortex contributes to depressive-/anxiogenic-like behavioral phenotype of mice subchronically exposed to dexamethasone. Journal of Chemical Neuroanatomy 100, pages 101663.
Crossref
Svitlana Antoniuk, Monika Bijata, Evgeni Ponimaskin & Jakub Wlodarczyk. (2019) Chronic unpredictable mild stress for modeling depression in rodents: Meta-analysis of model reliability. Neuroscience & Biobehavioral Reviews 99, pages 101-116.
Crossref
Max A. Lazar & Roger S. McIntyre. 2019. Neurobiology of Depression. Neurobiology of Depression 383 400 .
Shivani Jaiswal, Rati Kailash Prasad Tripathi & Senthil Raja Ayyannan. (2018) Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation. Biomedicine & Pharmacotherapy 107, pages 1611-1623.
Crossref
Tongtong Ge, Jie Fan, Wei Yang, Ranji Cui & Bingjin Li. (2018) Leptin in depression: a potential therapeutic target. Cell Death & Disease 9:11.
Crossref
F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva & F. Drago. (2018) International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets. Pharmacological Reviews 70:3, pages 475-504.
Crossref
Chong Gao, Xingmiao Chen, Aimin Xu, Kenneth Cheng & Jiangang Shen. (2017) Adaptor Protein APPL2 Affects Adult Antidepressant Behaviors and Hippocampal Neurogenesis via Regulating the Sensitivity of Glucocorticoid Receptor. Molecular Neurobiology 55:7, pages 5537-5547.
Crossref
Gaurav Bedse, Rebecca J. Bluett, Toni A. Patrick, Nicole K. Romness, Andrew D. Gaulden, Philip J. Kingsley, Niels Plath, Lawrence J. Marnett & Sachin Patel. (2018) Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. Translational Psychiatry 8:1.
Crossref
Caren J. Blacker, Charles P. Lewis, Mark A. Frye & Marin Veldic. (2017) Metabotropic glutamate receptors as emerging research targets in bipolar disorder. Psychiatry Research 257, pages 327-337.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.